Updated June 30 at 3:30pm
Biotechnology
62 results total, viewing 31 - 40
Nabsys Inc., a life sciences company that was trying to bring its genome-mapping products to market, closed recently, throwing approximately 40 people out of work. more
U.S. stocks rose for the first time since Britain voted to leave the European Union, rebounding amid optimism that policymakers are committed to limit the fallout from the U.K.’s exit. more
After sitting out for most of the biotech acquisition frenzy of 2015, Amgen Inc. is ready to do a deal. more
A national consultant has advised the I-195 Redevelopment District Commission to create a business innovation district in Providence that is larger than the existing footprint of undeveloped land, and to create an advisory council that would include the perspectives of anchor industries and universities. more
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases. more
Katherine Gordon, managing director of the Technology Ventures Office at Brown University, discusses the mission of the office with Providence Business News. Gordon, who has been in her position for seven years, also talked about how the proposed Wexford Science & Technology innovation center project could lure additional companies to Rhode Island. more
When the University of Rhode Island’s Department of Cell and Microbiology saw an opportunity to help address the needs of Rhode Island’s biotech and pharmaceutical companies and satisfy student interest, it ran with it. more
CVS Health Corp. pays among the highest taxes in the nation, according to WalletHub, which released its S&P 100 tax rates report on Wednesday. more
EpiVax and French pharmaceutical company Ipsen recently announced a collaborative project to combat neurotoxins with novel biologic therapeutics. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 Next »